University of Tasmania
Browse

File(s) not publicly available

Capsaicin-induced biphasic oxygen uptake in rat muscle: antagonism by capsazepine and ruthenium red provides further evidence for peripheral vanilloid receptor subtypes (VN1/VN2)

journal contribution
posted on 2023-05-16, 10:08 authored by Griffiths, CD, Eldershaw, TPD, Dominic Geraghty, Hall, JL, Colquhoun, EQ
Previous studies with the vanilloid spice principle capsaicin have demonstrated a biphasic VO 2 response, with vasoconstriction, in the perfused rat hindlimb that has led to suggestions of vanilloid receptor subtypes (VN 1/VN 2) in this preparation (1). In the present study, the known competitive vanilloid antagonist capsazepine inhibited the above capsaicin- mediated effects in a manner that was indicative of binding at specific vanilloid recognition sites. Low concentrations of capsazepine selectively inhibited the increased VO 2 produced by the putative VN 1 receptor at submicromolar concentrations of capsaicin, while the inhibition of VO 2 produced by high concentrations of capsaicin (putative VN 2) was enhanced. These observations, showing different susceptibilities to blockade by capsazepine, further support the presence of two vanilloid receptor subtypes in the rat hindlimb. Schild plots of the data yielded variable slopes that approach unity at greater responses to capsaicin (mean K(B) = 8.44 ± 2.08 μM and 7.28 ± 0.78 μM for VO 2 and perfusion pressure curves, respectively). Low concentrations of the capsaicin antagonist ruthenium red selectively blocked the putative VN 2 receptor-mediated effects produced by high concentrations of capsaicin. The noncompetitive nature of this inhibitor suggests an operation through separate receptor-coupled ion channel complexes at high and low concentrations of the vanilloid. Tetrodotoxin failed to attenuate any changes produced by capsaicin, suggesting that the mechanism of action of capsaicin in the rat hindlimb may differ from other tissues.

History

Publication title

Life Sciences

Volume

59

Pagination

105-117

ISSN

0024-3205

Department/School

Tasmanian School of Medicine

Publisher

Pergamon-Elsevier Science Ltd

Place of publication

United States of America

Repository Status

  • Restricted

Socio-economic Objectives

Other health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC